Enfuvirtide (T-20) Peptide

Enfuvirtide (T-20) Peptide

€261.00
In stock
SKU
350164
Catalog Number: 350164
Size: 1 mg
Datasheet
Request Information
Protein Family: Receptors and Channels

Pathway and Disease: Immune System, Infectious Diseases

Alternate Names: Enfuvirtide; Fuzeon; envelope glycoprotein gp160; glycoprotein 120

Accession No.: P03375

Description:
Enfuvirtide is an envelope fusion inhibitor used to treat HIV-infected patients. The peptide binds to the HIV envelope glycoprotein gp41 and prevents viral fusion with the target cell membrane. Enfuvirtide (Fuzeon/Roche) was approved by the FDA in 2003.

Format:
Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt.

MW: 4492 g/mol

Sequence:
Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 or H-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2

Composition:
C204H301N51O64

Purity:
> 95% by HPLC

Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.

Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:Enfuvirtide (T-20) Peptide